Literature DB >> 26443384

The role of miRNAs in endometrial cancer.

Diamantina Vasilatou1, Vasileios D Sioulas2, Vasiliki Pappa1, Sotirios G Papageorgiou1, Nikolaos F Vlahos3.   

Abstract

miRNAs are small noncoding RNAs that regulate gene expression at the post-transcriptional level. Since their discovery, miRNAs have been associated with every cell function including malignant transformation and metastasis. Endometrial cancer is the most common gynecologic malignancy. However, improvement should be made in interobserver agreement on histological typing and individualized therapeutic approaches. This article summarizes the role of miRNAs in endometrial cancer pathogenesis and treatment.

Entities:  

Keywords:  endometrial cancer; metastasis; miR-200; miRNAs

Mesh：

Substances：

Year:  2015        PMID： 26443384     DOI： 10.2217/epi.15.41

Source DB:  PubMed          Journal:  Epigenomics        ISSN： 1750-192X            Impact factor:   4.778


  10 in total

1.  Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer.

Authors:  Hualin Song; Tianjie Li; Jindong Sheng; Dan Li; Xiangyu Liu; Huiting Xiao; Hu Yu; Wenxin Liu; Ke Wang; Ying Chen
Journal:  Front Genet       Date:  2022-05-27       Impact factor: 4.772

Review 2.  MicroRNAs in the Regulation of Endometrial Receptivity for Embryo Implantation.

Authors:  Manizha Shekibi; Sophea Heng; Guiying Nie
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 3.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

4.  A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer.

Authors:  Jie Chai; Dawei Guo; Wanli Ma; Dali Han; Wei Dong; Hongliang Guo; Yi Zhang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

5.  Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.

Authors:  Cecilia Higgs; James E Hilbert; Libby Wood; William B Martens; Chiara Marini-Bettolo; Nikoletta Nikolenko; Rotana Alsaggaf; Hanns Lochmüller; Richard T Moxley; Mark H Greene; Youjin Wang; Shahinaz M Gadalla
Journal:  Front Neurol       Date:  2019-10-11       Impact factor: 4.003

6.  MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells.

Authors:  Jiping Wang; Li Zhang; Wenyan Jiang; Rongkui Zhang; Bei Zhang; Aidaeraili Silayiding; Xiumei Duan
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-11-15

7.  Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling.

Authors:  Na Wang; Yunfeng Guo; Liqin Song; Tong Tong; Xiaomei Fan
Journal:  J Gynecol Oncol       Date:  2021-10-25       Impact factor: 4.401

8.  DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile.

Authors:  Oliver Treeck; Florian Weber; Juergen Fritsch; Maciej Skrzypczak; Susanne Schüler-Toprak; Christa Buechler; Olaf Ortmann
Journal:  Biomedicines       Date:  2022-07-18

9.  Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.

Authors:  Qian Wang; Kai Xu; Yu Tong; Xianning Dai; Teng Xu; Danna He; Jianchao Ying
Journal:  J Cell Mol Med       Date:  2020-03-09       Impact factor: 5.310

10.  Circ_0109046 Promotes the Progression of Endometrial Cancer via Regulating miR-136/HMGA2 Axis.

Authors:  Yanping Shi; Li Jia; Hongli Wen
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.